Characteristics of Patients with Heart Failure and Advanced Chronic Kidney Disease (Stages 4-5) Not Undergoing Renal Replacement Therapy (ERCA-IC Study)

被引:4
|
作者
More, Sandra Valdivielso [1 ,2 ,3 ]
Elcano, Miren Vicente [1 ]
Alonso, Anna Garcia [1 ]
Sanchez, Sergi Pascual [4 ]
Herrera, Isabel Galceran [4 ]
Puig, Francesc Barbosa [4 ]
Belarte-Tornero, Laia C. [1 ,2 ,3 ]
Ruiz-Bustillo, Sonia [1 ,2 ,5 ]
Murillo, Ronald O. Morales O. [1 ,2 ]
Barrios, Clara [4 ]
Vime-Jubany, Joan [1 ]
Farre, Nuria [1 ,2 ,5 ]
机构
[1] Hosp del Mar, Dept Cardiol, Heart Failure Unit, Barcelona 08003, Spain
[2] Hosp Mar Med Res Grp IMIM, Biomed Res Grp Heart Dis, Barcelona 08003, Spain
[3] Univ Autonoma Barcelona, Dept Med, Barcelona 08193, Spain
[4] Hosp Mar, Dept Nephrol, Barcelona 08003, Spain
[5] Univ Pompeu Fabra, Dept Med, Barcelona 08002, Spain
关键词
advanced chronic kidney disease; cardiorenal; heart failure; kidney dysfunction; prognosis; mortality; CARDIOVASCULAR EVENTS; HOSPITALIZATION; DIALYSIS;
D O I
10.3390/jcm12062339
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Despite the frequent coexistence of heart failure (HF) in patients with advanced chronic kidney disease (CKD), it has been understudied, and little is known about its prevalence and prognostic relevance. Methods: A retrospective study of 217 patients with advanced CKD (stages 4 and 5) who did not undergo renal replacement therapy (RRT). The patients were followed up for two years. The primary outcome was all-cause death or the need for RRT. Results: Forty percent of patients had a history of HF. The mean age was 78.2 +/- 8.8 years and the mean eGFR was 18.4 +/- 5.5 mL/min/1.73 m(2). The presence of previous HF identified a subgroup of high-risk patients with a high prevalence of cardiovascular comorbidities and was significantly associated with the composite endpoint of all-cause hospitalization or need for RRT (66.7% vs. 53.1%, HR 95% CI 1.62 (1.04-2.52), p = 0.034). No differences were found in the need for RRT (27.6% vs. 32.2%, p = 0.46). Nineteen patients without HF at baseline developed HF during the follow-up and all-cause death was numerically higher (36.8 vs. 19.8%, p = 0.1). Conclusions: Patients with advanced CKD have a high prevalence of HF. The presence of previous HF identified a high-risk population with a worse prognosis that required close follow-up.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] The association of urinary sodium excretion and the need for renal replacement therapy in advanced chronic kidney disease: a cohort study
    Andrea Mazarova
    Amber O. Molnar
    Ayub Akbari
    Manish M. Sood
    Swapnil Hiremath
    Kevin D. Burns
    Timothy O. Ramsay
    Ranjeeta Mallick
    Gregory A. Knoll
    Marcel Ruzicka
    BMC Nephrology, 17
  • [22] The association of urinary sodium excretion and the need for renal replacement therapy in advanced chronic kidney disease: a cohort study
    Mazarova, Andrea
    Molnar, Amber O.
    Akbari, Ayub
    Sood, Manish M.
    Hiremath, Swapnil
    Burns, Kevin D.
    Ramsay, Timothy O.
    Mallick, Ranjeeta
    Knoll, Gregory A.
    Ruzicka, Marcel
    BMC NEPHROLOGY, 2016, 17
  • [23] VASCULARCALCIFICATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGES 4, 5 AND 5D:RECAVAS STUDY
    Luis Gorriz, Jose
    Molina, Pablo
    Escudero, Veronica
    Baltran, Sandra
    Dolores Del Pino, Ma
    Salgueira, Mercedes
    Castro, Cristina
    Pantoja, Jonay
    Gonzalez-Moya, Mercedes
    Pallardo, Luis
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 1471 - 1471
  • [24] Health-related quality of life in kidney transplant patients and non-renal replacement therapy patients with chronic kidney disease stages 3b-4
    Stomer, Une
    Bergrem, Harald
    Goransson, Lasse G.
    ANNALS OF TRANSPLANTATION, 2013, 18 : 635 - 642
  • [25] Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study
    He, Jiang
    Shlipak, Michael
    Anderson, Amanda
    Roy, Jason A.
    Feldman, Harold I.
    Kallem, Radhakrishna Reddy
    Kanthety, Radhika
    Kusek, John W.
    Ojo, Akinlolu
    Rahman, Mahboob
    Ricardo, Ana C.
    Soliman, Elsayed Z.
    Wolf, Myles
    Zhang, Xiaoming
    Raj, Dominic
    Hamm, Lee
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (05):
  • [26] Effectiveness and safety of anakinra in gout patients with stage 4-5 chronic kidney disease or kidney transplantation: A multicentre, retrospective study
    Loustau, Clotilde
    Rosine, Nicolas
    Forien, Marine
    Ottaviani, Sebastien
    Juge, Pierre-Antoine
    Liote, Frederic
    Bardin, Thomas
    Richette, Pascal
    Dieude, Philippe
    Richez, Christophe
    Bannwarth, Bernard
    Schaeverbeke, Thierry
    Ea, Hang-Korng
    Truchetet, Marie-Elise
    JOINT BONE SPINE, 2018, 85 (06) : 755 - 760
  • [27] Age-related differences in renal function at onset of renal replacement therapy in chronic kidney disease stage 5 patients
    Balogun, S. A.
    Balogun, R. A.
    Evans, J.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2006, 99 (09) : 595 - 599
  • [28] Effects of hyperuricemia on incident renal replacement therapy and all-cause mortality among patients with chronic kidney disease stages 3-5: a retrospective cohort study
    Lee, Chia-Lin
    Wang, Jun-Sing
    SAO PAULO MEDICAL JOURNAL, 2019, 137 (06): : 523 - 529
  • [29] Assessment of physical activity in patients with chronic kidney disease and renal replacement therapy (vol 4, 536, 2015)
    Hayhurst, William S. G.
    Ahmed, Aimun
    SPRINGERPLUS, 2016, 5
  • [30] A qualitative analysis of eating behaviour change for patients with diabetes and non-dialysis dependent chronic kidney disease stages 4-5
    Notaras, Stephanie
    Conti, Janet
    JOURNAL OF RENAL CARE, 2018, 44 (04) : 219 - 228